Skip to main content
. 2021 Apr 26;22(9):4526. doi: 10.3390/ijms22094526

Figure 3.

Figure 3

Pathologies such as myocardial infarction, hypertension, diabetes mellitus and heart failure increase the availability of ACE2 suggesting that comorbidities cause high susceptibility towards SARS-CoV-2. ADAM17, ADAM metallopeptidase domain 17; ACE2, angiotensin-converting enzyme 2; sACE2, soluble ACE2.